Vega Investment Solutions Acquires New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vega Investment Solutions bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 8,927 shares of the medical equipment provider's stock, valued at approximately $4,660,000. Intuitive Surgical makes up about 3.8% of Vega Investment Solutions' portfolio, making the stock its 7th largest holding.

Several other large investors also recently added to or reduced their stakes in ISRG. Atala Financial Inc bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $25,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $26,000. Parvin Asset Management LLC bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $28,000. Finally, Hurley Capital LLC bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $28,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $542.67 on Friday. The stock has a market cap of $194.50 billion, a P/E ratio of 84.66, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a one year low of $396.15 and a one year high of $616.00. The company has a fifty day moving average price of $510.44 and a 200 day moving average price of $537.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the company earned $1.50 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In other news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 188 shares of the stock in a transaction on Friday, February 28th. The shares were sold at an average price of $566.94, for a total transaction of $106,584.72. Following the completion of the transaction, the chief financial officer now owns 7,162 shares of the company's stock, valued at approximately $4,060,424.28. This represents a 2.56% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 32,700 shares of company stock worth $16,865,621. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have commented on ISRG. Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Royal Bank of Canada reduced their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. UBS Group boosted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research note on Monday, January 27th. Citigroup restated a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday. Finally, Piper Sandler reduced their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.